Results
6,850 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Halio CareyGlobal Treasurer |  GSGOLDMAN SACHS GROUP INCOpen-market sale | SELL | $103K 112 sh | Jan 29, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $103K 112 sh | Jan 29, 2026 |
| 32 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $200K 216 sh | Jan 29, 2026 traded Jan 27, 2026 |
| 32 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $86K 92 sh | Jan 29, 2026 traded Jan 27, 2026 |
| 30 | Hahnfeld Jeffrey DEVP-CONTROLLER & CHIEF ACC OFF |  WTFCWINTRUST FINANCIAL CORPOpen-market sale | SELL | $46K 314 sh | Jan 29, 2026 traded Jan 27, 2026 |
| 66 | Nelson Jeffrey EdwardChief Operating Officer |  MISTMilestone Pharmaceuticals Inc.Open-market sale | SELL | $135K 58.0K sh | Jan 28, 2026 traded Dec 15, 2025 |
| 62 | Hasija AmitCFO & EVP of Corp. Development | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $135K 58.0K sh | Jan 28, 2026 traded Dec 15, 2025 |
| 62 | Bharucha DavidChief Medical Officer | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $135K 58.0K sh | Jan 28, 2026 traded Dec 15, 2025 |
| 62 | Muller LorenzChief Commercial Officer | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $124K 53.6K sh | Jan 28, 2026 traded Dec 15, 2025 |
| 38 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $78K 731 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 38 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $132K 1,238 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 38 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $78K 730 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 38 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $132K 1,239 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 37 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $691K 7,007 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 37 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $691K 7,007 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 37 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $631K 6,209 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 37 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $631K 6,209 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.84M 28.8K sh | Jan 28, 2026 traded Jan 26, 2026 |
| 36 | Nelson Jeffrey EdwardChief Operating Officer | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $24K 12.2K sh | Jan 28, 2026 traded Jan 26, 2026 |
| 36 | Muller LorenzChief Commercial Officer | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $22K 11.2K sh | Jan 28, 2026 traded Jan 26, 2026 |
| 36 | Bharucha DavidChief Medical Officer | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $24K 12.2K sh | Jan 28, 2026 traded Jan 26, 2026 |
| 36 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.60M 25.5K sh | Jan 28, 2026 traded Jan 26, 2026 |
| 36 | Hasija AmitCFO & EVP of Corp. Development | MISTMilestone Pharmaceuticals Inc. Open-market sale | SELL | $24K 12.2K sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $7,776 73 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 243 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 218 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $7,776 73 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 254 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 413 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,179 85 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 255 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 35 | Spencer CourtneyChief Experience Officer |  LOBLive Oak Bancshares, Inc.Open-market sale | SELL | $378K 9,700 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 589 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $210K 2,070 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $56K 534 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $186K 1,767 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $230K 2,336 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 1,602 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | Benkowitz MichaelPRESIDENT AND COO |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $736K 1,573 sh | Jan 28, 2026 traded Jan 20, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 763 sh | Jan 28, 2026 traded Jan 26, 2026 |
| 34 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $185K 1,766 sh | Jan 28, 2026 traded Jan 26, 2026 |